Immunovant shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Immunovant (IMVT) shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Immunovant
Tip: Access up to 7 years of quarterly data
All positions including Immunovant held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Immunovant by Jpmorgan Chase & Co
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2023-12-31 | $20M | 471k | 42.13 |
| 2023-09-30 | $17M | 429k | 38.39 |
| 2023-06-30 | $8.4M | 443k | 18.97 |
| 2023-03-31 | $961k | 62k | 15.50 |
| 2022-12-31 | $895k | 50k | 17.75 |
| 2022-06-30 | $2.5M | 653k | 3.83 |
| 2022-03-31 | $2.5M | 462k | 5.52 |
| 2021-12-31 | $1.3M | 151k | 8.50 |
| 2021-03-31 | $406k | 25k | 16.07 |
| 2020-12-31 | $962k | 21k | 46.09 |
| 2020-09-30 | $627k | 17k | 36.42 |
| 2020-06-30 | $391k | 16k | 24.34 |
| 2020-03-31 | $45k | 2.9k | 15.47 |